glp 1 microdosing for autoimmune Association between diseases and glucagon-like peptide-1 receptor agonists: A real-world evidence study What Is Microdosing GLP-1? Full

the Stockholm CREAtinine Measurements (SCREAM) project

M.SofopoulosM.TsoukasM

Ethics declarations Competing interests The authors declare no competing interests

Sodium-glucose cotransport protein 1 (SGLT1) is a proximal glucose transporter responsible for absorbing glucose across the intestinal brush border, and it realizes glucose concentration gradient transport by coupling the uptake of each glucose molecule to the inward flux of two Na + ions

This treatment option can be used as primary and secondary prevention

A prospective study found (189) that 1 year after bariatric surgery, NASH was eliminated in 85% of patients, indicating that weight loss was closely related to the histological improvement of fatty liver